Skip to content
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Menu
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Happy News

Every Patient In This Bowel Cancer Trial Has Been Cancer Free For Nearly Three Years

In one of the most striking results from any cancer clinical trial in recent years, every single patient in a bowel cancer study has remained cancer-free for nearly three years after receiving a short course of immunotherapy before surgery, with zero relapses recorded in the entire cohort as of the latest follow-up data. The NEOPRISM-CRC trial, led by researchers at University College London and University College London Hospitals, gave patients with a specific form of stage two or three bowel cancer nine weeks of pre-operative treatment with the immunotherapy drug pembrolizumab, replacing the conventional approach of post-operative chemotherapy. Initial results showed that 59 percent of patients had no detectable cancer after the immunotherapy and surgery combined, and the new follow-up data at 33 months shows that not only have those patients remained clear, but even the patients who still had small amounts of cancer remaining after treatment saw none of it grow or spread. Under the standard treatment pathway, roughly 25 percent of similar patients would be expected to relapse within three years.

The results were presented at the American Association for Cancer Research Annual Meeting in April 2026 and have generated significant excitement among oncologists. The specific bowel cancer treated in the trial, known as mismatch repair-deficient cancer, affects roughly 15 percent of all bowel cancer patients and is characterized by genetic errors that make it particularly responsive to immunotherapy. Researchers noted that the results suggest a nine-week drug course could replace months of chemotherapy and provide more durable protection against recurrence, a potential shift in how this form of the disease is treated from the ground up. Scientists called the zero-relapse figure at nearly three years extraordinary, and said larger trials are now needed to confirm and extend the findings across wider patient populations.

Source: https://scitechdaily.com/breakthrough-bowel-cancer-trial-leaves-patients-cancer-free-for-nearly-3-years/

PrevPreviousColorado Just Banned Pet Store Dog And Cat Sales
NextA 12-Year-Old Fighting Brain Cancer Raised $22 At A Lemonade Stand For Research And Then Something Incredible HappenedNext

Recent Articles

Happy News

The Internet Just Voted On The Funniest Wildlife Photo Of The Year And The Winner Is Perfect

May 2, 2026

The internet has voted, and the winner of the Nikon Comedy Wildlife Awards’ Sterna People’s Choice Award is a deeply relatable photograph of a gannet on a very bad hair day. UK photographer Alison Tuck captured the winning shot on a breezy afternoon at Bempton Cliffs in Yorkshire during nesting

Read More
Happy News

Scientists Just Found The Fossilized Remains Of A Snake That May Have Been Up To 50 Feet Long

May 2, 2026

Paleontologists working in India have announced the discovery of one of the largest snakes ever to have lived on Earth, a prehistoric giant called Vasuki indicus that slithered across what is now the state of Gujarat roughly 47 million years ago and is estimated to have reached a staggering length

Read More
Happy News

The Worlds Oldest Penguin Just Turned 38 And Her Birthday Cake Was Exactly What You Would Hope

May 2, 2026

A Humboldt penguin named Spneb has just celebrated her 38th birthday at Paradise Park Wildlife Sanctuary in Hayle, Cornwall, making her the oldest Humboldt penguin on the planet according to global zoo records, with a lifespan that has nearly doubled the species’ typical life expectancy in captivity. Keepers marked the

Read More
« Previous Next »
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
Copyright © 2026 HappyNews.